Interviews

Lee Newcomer, MD, MHA, of Oncology, Genetics and Women's Health for UnitedHealthcare, says the National Comprehensive Cancer Network is transforming genetic testing by utilizing a tool called the NCCN Biomarkers Compendium, which encourages evidence-based decision-making.

Peter B. Bach, MD, MAPP, director, Center for Health Policy and Outcomes, says accountable care organizations and patient-centered medical homes are trends driven by macro issues, which include decreased reimbursement to private practices and drug discounts from the 340B program.

The STABLE study compared patients who took weekly tests compared with those who tested less regularly, and found that those who tested weekly had better results than those who did not.

Farzad Mostashari, MD, visiting fellow, Brookings Institution, former national coordinator for health information technology (HIT), US Department of Health and Human Services (HHS), discusses how data and digitization are driving innovation in healthcare.

Peter B. Bach, MD, MAPP, director, Center for Health Policy and Outcomes, and attending physician at Memorial Sloan-Kettering Cancer Center, says accountable care organizations (ACOs) and patient-centered medical homes (PCMHs) may have the potential to drive cost savings, especially in clinical areas such as readmissions.

David B. Hoyt, MD, FACS, executive director, American College of Surgeons (ACS), says their National Surgical Improvement Program is designed to help hospitals evaluate where they stand with certain complications, and to then help them through a series of techniques to improve the care around those complications.

Brand Logo

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences®

All rights reserved.

Secondary Brand Logo